SI2413949T1 - Inhibicija biofilmskih organizmov - Google Patents

Inhibicija biofilmskih organizmov

Info

Publication number: SI2413949T1
Authority: SI; Slovenia
Prior art keywords: inhibition; biofilm organisms; biofilm; organisms
Prior art date: 2009-03-31

Application number

SI201031825T

Other languages

English (en)

Inventor

Deborah O'neil

Derry Mercer

Cedric Charrier

Original Assignee

Novabiotics Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-31

Filing date

2010-03-31

Publication date

2019-02-28

2010-03-31 Application filed by Novabiotics Limited filed Critical Novabiotics Limited

2019-02-28 Publication of SI2413949T1 publication Critical patent/SI2413949T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/424—Anti-adhesion agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Zoology (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Dermatology (AREA)
Plant Pathology (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Pest Control & Pesticides (AREA)
Agronomy & Crop Science (AREA)
Environmental Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201031825T 2009-03-31 2010-03-31 Inhibicija biofilmskih organizmov SI2413949T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US16539609A	2009-03-31	2009-03-31
GBGB0905451.1A GB0905451D0 (en)	2009-03-31	2009-03-31	Biofilms
EP10715573.1A EP2413949B1 (en)	2009-03-31	2010-03-31	Inhibition of biofilm organisms
PCT/GB2010/000631 WO2010112848A2 (en)	2009-03-31	2010-03-31	Inhibition of biofilm organisms

Publications (1)

Publication Number	Publication Date
SI2413949T1 true SI2413949T1 (sl)	2019-02-28

Family

ID=40671951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201031825T SI2413949T1 (sl)	2009-03-31	2010-03-31	Inhibicija biofilmskih organizmov

Country Status (21)

Country	Link
US (3)	US9339525B2 (sl)
EP (1)	EP2413949B1 (sl)
JP (1)	JP5727994B2 (sl)
KR (1)	KR101852784B1 (sl)
CN (2)	CN104257645A (sl)
AU (2)	AU2010231136B2 (sl)
BR (1)	BRPI1012219C1 (sl)
CA (1)	CA2755878C (sl)
CY (1)	CY1121175T1 (sl)
GB (1)	GB0905451D0 (sl)
IL (1)	IL215369B2 (sl)
MX (1)	MX358018B (sl)
NZ (1)	NZ595037A (sl)
PL (1)	PL2413949T3 (sl)
RU (1)	RU2548786C2 (sl)
SG (2)	SG10201400926VA (sl)
SI (1)	SI2413949T1 (sl)
TR (1)	TR201821161T4 (sl)
UA (1)	UA106743C2 (sl)
WO (1)	WO2010112848A2 (sl)
ZA (1)	ZA201107140B (sl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0811530B1 (pt)	2007-05-14	2019-01-02	Research Foundation Of State Univ Of New York	composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
GB0905451D0 (en) *	2009-03-31	2009-05-13	Novabiotics Ltd	Biofilms
TWI403330B (zh) *	2010-03-29	2013-08-01	Rise technology co ltd	低血球溶解性之抗微生物胜肽、醫藥組成物及其用途
GB201016733D0 (en) *	2010-10-05	2010-11-17	Novabiotics Ltd	Compounds and their use
MX340520B (es)	2010-04-27	2016-07-12	Lysando Ag *	Metodo de reduccion de biopeliculas.
GB201021186D0 (en) *	2010-12-14	2011-01-26	Novabiotics Ltd	Composition
US20140154235A1 (en)	2011-05-12	2014-06-05	Smith & Nephew Orthopaedics Ag	Wound debridement compositions containing seaprose and methods of wound treatment using same
TWI415572B (zh)	2011-06-17	2013-11-21	Univ Chang Gung	利用１，２，３，４，６－五－ｏ－沒食子醯基－ｄ－葡哌喃糖來抑制生物膜形成
WO2013076666A1 (en) *	2011-11-23	2013-05-30	Newsouth Innovations Pty Limited	Antimicrobial peptides and uses thereof
CN104582688A (zh) *	2012-03-23	2015-04-29	艾麦克罗比公司	具有组织相容性的抗菌材料组合物及其用途
AU2013259360B2 (en) *	2012-05-11	2017-07-13	Smith & Nephew, Inc.	Use of Seaprose to remove bacterial biofilm
WO2014016979A1 (ja) *	2012-07-27	2014-01-30	住友重機械工業株式会社	微生物活性調節剤及び微生物の活性を調節する方法
EP3038638A4 (en) *	2013-08-27	2017-09-13	The University Of British Columbia	Small cationic anti-biofilm and idr peptides
GB201405891D0 (en) *	2014-04-02	2014-05-14	Novabiotics Ltd	Modified antimicrobial peptides
US20160102052A1 (en) *	2014-09-22	2016-04-14	Novabiotics Limited	Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
GB201416727D0 (en) *	2014-09-22	2014-11-05	Novabiotics Ltd	Use
GB201510077D0 (en) *	2015-06-10	2015-07-22	Novabiotics Ltd	Use
US11103547B2 (en)	2016-02-04	2021-08-31	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods for disrupting biofilms
US20210213096A1 (en) *	2016-02-19	2021-07-15	Forschungszentrum Borstel Leibniz-Zentrum Fur Medizin Und Biowssenschaften	Means and methods for treating bacterial infections
WO2017176796A1 (en)	2016-04-04	2017-10-12	University Of Virginia Patent Foundation	Compositions and methods for preventing and treating disease
EP3241570A1 (en) *	2016-05-02	2017-11-08	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Polypeptide and hyaluronic acid coatings
JP7249149B2 (ja) *	2016-05-12	2023-03-30	ザトラスティーズオブザユニバーシティオブペンシルバニア	バイオフィルムの堆積および産生を阻害するための組成物および方法
WO2017212239A1 (en) *	2016-06-07	2017-12-14	Novabiotics Limited	Treatment of drug-resistant microbial infections
US11628207B2 (en)	2016-07-27	2023-04-18	Smith & Nephew, Inc.	Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
EP3861994A1 (en) *	2016-12-15	2021-08-11	Zambon S.p.A.	N-acetylcysteine for use as antibiofilm agent
AU2017381394A1 (en) *	2016-12-22	2019-07-25	The University Of Sydney	Biofilm disrupting composition
AU2018205685B2 (en) *	2017-01-05	2023-03-16	Cormedix Inc.	Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilms
US11413300B2 (en)	2017-01-30	2022-08-16	Smith & Nephew, Inc.	Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
EP3606543A4 (en)	2017-04-06	2020-12-16	Amicrobe, Inc.	COMPOSITIONS AND USES OF LOCALLY APPLIED ANTIMICROBIALS WITH IMPROVED PERFORMANCE AND SAFETY
RU2664708C1 (ru) *	2017-06-08	2018-08-21	Сергей Иванович Черныш	Способ разрушения и предотвращения образования бактериальных биопленок комплексом антимикробных пептидов насекомых
CN108048359B (zh) *	2017-12-27	2020-12-01	广州立白企业集团有限公司	一种牙菌斑生物膜模型的培养方法和优化的生物膜活菌计数法及应用
US20220249599A1 (en) *	2018-03-13	2022-08-11	Peptilogics, Inc.	Treatment of implants with engineered antimicrobial amphiphilic peptides
CN108753632A (zh) *	2018-05-25	2018-11-06	安徽中医药大学	一种溶解白念珠菌生物被膜胞外基质的方法
US11541105B2 (en)	2018-06-01	2023-01-03	The Research Foundation For The State University Of New York	Compositions and methods for disrupting biofilm formation and maintenance
PL3866775T3 (pl) *	2018-10-17	2025-07-07	Novabiotics Limited	Cysteamina do zastosowania w leczeniu chorób płuc
CN110402928A (zh) *	2019-08-08	2019-11-05	杭州博菲医疗器械有限公司	一种抑菌功能液及应用该抑菌功能液的导管组件
CN110583697B (zh) *	2019-09-20	2021-04-06	浙江工商大学	去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
CN111675751B (zh) *	2020-04-08	2022-06-14	天津医科大学口腔医院	一种抗菌肽及其应用
GB202010268D0 (en) *	2020-07-03	2020-08-19	Novabiotics Ltd	Nail formulations and treatment regimes
US12371463B2 (en)	2021-04-20	2025-07-29	University of Pittsburgh—of the Commonwealth System of Higher Education	Methods and compositions for treatment of antibiotic-resistant bacterial infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1055560B (it) *	1974-05-02	1982-01-11	Istituto Chemioterapico	Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
AU2042200A (en) *	1998-12-07	2000-06-26	Baylor College Of Medicine	Preventing and removing biofilm from the surface of medical devices
ITMI20021881A1 (it) *	2002-09-04	2004-03-05	Zambon Spa	Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
GB2398497A (en) *	2003-02-19	2004-08-25	Walcom Animal Science	Composition for improving immunity of animals
DK1778720T3 (da) *	2004-08-18	2010-11-29	Novabiotics Ltd	Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv
WO2007050565A2 (en) *	2005-10-25	2007-05-03	Baylor College Of Medicine	Incorporation of antimicrobial combinations onto devices to reduce infection
AR057623A1 (es) *	2005-11-28	2007-12-05	Omega Bio Pharma H K Ltd	Materiales y metodos para el tratamiento de las infecciones virales
ZA200805191B (en) *	2005-11-28	2009-08-26	Hk Omega Biopharma Ltd	Materials and methods for treating viral infections with a cysteamine compound
GB0702021D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
JP2010528053A (ja) *	2007-05-25	2010-08-19	オメガバイオ−ファルマ（エイチ．ケイ．）リミテッド	インフルエンザ感染症を治療するための物質および方法
WO2009100950A1 (en) *	2008-02-17	2009-08-20	Walcom Animal Science (I.P.3) Limited	Materials and methods for improving the health of shrimp
GB0905451D0 (en) *	2009-03-31	2009-05-13	Novabiotics Ltd	Biofilms
GB201021186D0 (en) *	2010-12-14	2011-01-26	Novabiotics Ltd	Composition
US20160106689A1 (en) *	2014-09-22	2016-04-21	Novabiotics Limited	Use
US20160102052A1 (en) *	2014-09-22	2016-04-14	Novabiotics Limited	Use of Cysteamine in Treating Infections caused by Yeasts/Moulds

2009
- 2009-03-31 GB GBGB0905451.1A patent/GB0905451D0/en not_active Ceased
2010
- 2010-03-31 EP EP10715573.1A patent/EP2413949B1/en active Active
- 2010-03-31 CA CA2755878A patent/CA2755878C/en active Active
- 2010-03-31 TR TR2018/21161T patent/TR201821161T4/tr unknown
- 2010-03-31 CN CN201410419543.7A patent/CN104257645A/zh active Pending
- 2010-03-31 AU AU2010231136A patent/AU2010231136B2/en not_active Ceased
- 2010-03-31 NZ NZ595037A patent/NZ595037A/xx unknown
- 2010-03-31 MX MX2011010258A patent/MX358018B/es active IP Right Grant
- 2010-03-31 SG SG10201400926VA patent/SG10201400926VA/en unknown
- 2010-03-31 US US13/260,547 patent/US9339525B2/en active Active
- 2010-03-31 UA UAA201110832A patent/UA106743C2/uk unknown
- 2010-03-31 WO PCT/GB2010/000631 patent/WO2010112848A2/en not_active Ceased
- 2010-03-31 CN CN201080014896.9A patent/CN102387794B/zh not_active Expired - Fee Related
- 2010-03-31 KR KR1020117024561A patent/KR101852784B1/ko active Active
- 2010-03-31 JP JP2012502770A patent/JP5727994B2/ja active Active
- 2010-03-31 SI SI201031825T patent/SI2413949T1/sl unknown
- 2010-03-31 SG SG2011064417A patent/SG174278A1/en unknown
- 2010-03-31 RU RU2011143399/15A patent/RU2548786C2/ru active
- 2010-03-31 PL PL10715573T patent/PL2413949T3/pl unknown
- 2010-03-31 BR BRPI1012219A patent/BRPI1012219C1/pt active IP Right Grant
2011
- 2011-09-25 IL IL215369A patent/IL215369B2/en unknown
- 2011-09-29 ZA ZA2011/07140A patent/ZA201107140B/en unknown
2016
- 2016-03-28 US US15/082,976 patent/US20160206575A1/en not_active Abandoned
- 2016-08-05 AU AU2016210742A patent/AU2016210742B2/en active Active
2019
- 2019-01-09 CY CY20191100019T patent/CY1121175T1/el unknown
- 2019-02-13 US US16/274,896 patent/US20190175528A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2016210742B2 (en)	2017-08-10
CN102387794B (zh)	2015-11-25
BRPI1012219A2 (pt)	2016-03-29
NZ595037A (en)	2013-07-26
MX2011010258A (es)	2011-10-19
SG174278A1 (en)	2011-10-28
CA2755878A1 (en)	2010-10-07
IL215369B2 (en)	2023-02-01
IL215369B (en)	2022-10-01
US20190175528A1 (en)	2019-06-13
JP5727994B2 (ja)	2015-06-03
RU2548786C2 (ru)	2015-04-20
MX358018B (es)	2018-08-02
PL2413949T3 (pl)	2019-04-30
ZA201107140B (en)	2012-06-27
AU2016210742A1 (en)	2016-08-25
EP2413949A2 (en)	2012-02-08
CA2755878C (en)	2018-04-24
CN104257645A (zh)	2015-01-07
EP2413949B1 (en)	2018-10-10
UA106743C2 (uk)	2014-10-10
US20160206575A1 (en)	2016-07-21
TR201821161T4 (tr)	2019-01-21
US20120189682A1 (en)	2012-07-26
CN102387794A (zh)	2012-03-21
BRPI1012219B8 (pt)	2020-05-12
US9339525B2 (en)	2016-05-17
BRPI1012219C1 (pt)	2021-05-25
CY1121175T1 (el)	2020-05-29
AU2010231136A1 (en)	2011-09-29
KR20120003893A (ko)	2012-01-11
IL215369A (en)	2013-02-03
SG10201400926VA (en)	2014-10-30
WO2010112848A3 (en)	2011-01-27
GB0905451D0 (en)	2009-05-13
AU2010231136B2 (en)	2016-08-04
JP2012522037A (ja)	2012-09-20
WO2010112848A2 (en)	2010-10-07
KR101852784B1 (ko)	2018-04-30

Publication	Publication Date	Title
SG10201400926VA (en)	2014-10-30	Inhibition of biofilm organisms
ZA201700326B (en)	2018-04-25	Inhibitors of beta-secretase
GB0919097D0 (en)	2009-12-16	Treatment of hard surfaces
ZA201102604B (en)	2012-09-26	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
GB0907886D0 (en)	2009-06-24	Corrosion inhibitor
PL2133419T3 (pl)	2019-02-28	Zastosowania beta-dipeptydów cyjanoficyny
SG10201404913QA (en)	2014-11-27	Inhibitors of cognitive decline
IL217833A0 (en)	2012-03-29	Inhibitors of cognitive decline
ZA201007418B (en)	2011-06-29	Arrangement for neutralisation of microorganisms
EP2296476A4 (en)	2013-11-06	HEMMER OF BACTERIAL BIOFILMATION
IL217756A0 (en)	2012-03-29	Inhibitors of jnk
EG26530A (en)	2014-01-29	Formulated to reduce the degree of water hardness
GB0916510D0 (en)	2009-10-28	Deposition of materials
EP2418208A4 (en)	2013-04-17	INHIBITOR OF INCREASE IN GIP RATE
HUE041752T2 (hu)	2019-05-28	Biofilm organizmusok gátlása
GB0908609D0 (en)	2009-06-24	New use of isoQC inhibitors
HK1166320A (en)	2012-10-26	Inhibitors of beta-secretase
GB0915468D0 (en)	2009-10-07	Get me out of here
HU0800656D0 (en)	2008-12-29	Effective use of tea-composition
GB0905280D0 (en)	2009-05-13	Novel uses of VEGFxxxb
GB0715788D0 (en)	2007-09-19	Inhibition of corrosion
GB0912788D0 (en)	2009-08-26	Corrosion inhibitor
GB0911084D0 (en)	2009-08-12	New use of statins
GB0914739D0 (en)	2009-09-30	Enzyme inhibition
GB0914742D0 (en)	2009-09-30	Enzyme inhibition